Literature DB >> 22988826

Treatment of chronic myelomonocytic leukemia with azacitidine.

Eric Wong, John F Seymour, Melita Kenealy, David Westerman, Kirsten Herbert, Michael Dickinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22988826     DOI： 10.3109/10428194.2012.730615

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

Review 1.  Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.

Authors:  Kristen B McCullough; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 2.  Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors:  Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-06       Impact factor: 10.047

3.  Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

Authors:  Ana Alfonso; Guillermo Montalban-Bravo; Koichi Takahashi; Elias J Jabbour; Tapan Kadia; Farhad Ravandi; Jorge Cortes; Zeev Estrov; Gautam Borthakur; Naveen Pemmaraju; Marina Konopleva; Carlos Bueso-Ramos; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2017-05-26       Impact factor: 10.047

4.  Efficacy and Safety of Hypomethylating Agents in Chronic Myelomonocytic Leukemia: A Single-Arm Meta-analysis.

Authors:  Xinhui Zheng; Liwei Lv; Xiangjun Li; Erlie Jiang
Journal:  Glob Med Genet       Date:  2022-04-08

Review 5.  Therapy for Chronic Myelomonocytic Leukemia in a New Era.

Authors:  Tamara K Moyo; Michael R Savona
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

6.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

7.  Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Authors:  Piyanuch Kongtim; Uday Popat; Antonio Jimenez; Sameh Gaballa; Riad El Fakih; Gabriela Rondon; Julianne Chen; Carlos Bueso-Ramos; Gautam Borthakur; Naveen Pemmaraju; Guillermo Garcia-Manero; Hagop Kantarjian; Amin Alousi; Chitra Hosing; Paolo Anderlini; Issa F Khouri; Partow Kebriaei; Borje S Andersson; Betul Oran; Katayoun Rezvani; David Marin; Elizabeth J Shpall; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-04       Impact factor: 5.742

Review 8.  Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.

Authors:  Anthony M Hunter; Ling Zhang; Eric Padron
Journal:  Curr Treat Options Oncol       Date:  2018-10-27

9.  Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.

Authors:  Raphael Itzykson; Pierre Fenaux; David Bowen; Nicholas C P Cross; Jorge Cortes; Theo De Witte; Ulrich Germing; Francesco Onida; Eric Padron; Uwe Platzbecker; Valeria Santini; Guillermo F Sanz; Eric Solary; Arjan Van de Loosdrecht; Luca Malcovati
Journal:  Hemasphere       Date:  2018-11-29

Review 10.  Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Authors:  Konstantinos Liapis; Ioannis Kotsianidis
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.